REPORT ID 6496

United States Tumor Ablation Market Report 2017

Publish Date
26-Dec-17
Pages
95
Format
Electronic (PDF)

In this report, the United States Tumor Ablation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Tumor Ablation in these regions, from 2012 to 2022 (forecast).

United States Tumor Ablation market competition by top manufacturers/players, with Tumor Ablation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    ????Angiodynamics
    ????Medtronic
    ????Boston Scientific
    ????Galil Medical
    ????Neuwave Medical
    ????Misonix
    ????Merit Medical
    ????Sonacare Medical
    ????EDAP TMS

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ????Radiofrequency (RF) Ablation
    ????Microwave Ablation
    ????Cryoablation
    ????Other Technologies
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    ????Liver Cancer
    ????Lung Cancer
    ????Kidney Cancer
    ????Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Tumor Ablation Market Report 2017
1 Tumor Ablation Overview
    1.1 Product Overview and Scope of Tumor Ablation
    1.2 Classification of Tumor Ablation by Product Category
        1.2.1 United States Tumor Ablation Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Tumor Ablation Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 ????Radiofrequency (RF) Ablation
        1.2.4 ????Microwave Ablation
        1.2.5 ????Cryoablation
        1.2.6 ????Other Technologies
    1.3 United States Tumor Ablation Market by Application/End Users
        1.3.1 United States Tumor Ablation Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 ????Liver Cancer
        1.3.3 ????Lung Cancer
        1.3.4 ????Kidney Cancer
        1.3.5 ????Others
    1.4 United States Tumor Ablation Market by Region
        1.4.1 United States Tumor Ablation Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Tumor Ablation Status and Prospect (2012-2022)
        1.4.3 Southwest Tumor Ablation Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Tumor Ablation Status and Prospect (2012-2022)
        1.4.5 New England Tumor Ablation Status and Prospect (2012-2022)
        1.4.6 The South Tumor Ablation Status and Prospect (2012-2022)
        1.4.7 The Midwest Tumor Ablation Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Tumor Ablation (2012-2022)
        1.5.1 United States Tumor Ablation Sales and Growth Rate (2012-2022)
        1.5.2 United States Tumor Ablation Revenue and Growth Rate (2012-2022)

2 United States Tumor Ablation Market Competition by Players/Suppliers
    2.1 United States Tumor Ablation Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Tumor Ablation Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Tumor Ablation Average Price by Players/Suppliers (2012-2017)
    2.4 United States Tumor Ablation Market Competitive Situation and Trends
        2.4.1 United States Tumor Ablation Market Concentration Rate
        2.4.2 United States Tumor Ablation Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Tumor Ablation Manufacturing Base Distribution, Sales Area, Product Type

3 United States Tumor Ablation Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Tumor Ablation Sales and Market Share by Region (2012-2017)
    3.2 United States Tumor Ablation Revenue and Market Share by Region (2012-2017)
    3.3 United States Tumor Ablation Price by Region (2012-2017)

4 United States Tumor Ablation Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Tumor Ablation Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Tumor Ablation Revenue and Market Share by Type (2012-2017)
    4.3 United States Tumor Ablation Price by Type (2012-2017)
    4.4 United States Tumor Ablation Sales Growth Rate by Type (2012-2017)

5 United States Tumor Ablation Sales (Volume) by Application (2012-2017)
    5.1 United States Tumor Ablation Sales and Market Share by Application (2012-2017)
    5.2 United States Tumor Ablation Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Tumor Ablation Players/Suppliers Profiles and Sales Data
    6.1 ????Angiodynamics
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Tumor Ablation Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 ????Angiodynamics Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 ????Medtronic
        6.2.2 Tumor Ablation Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 ????Medtronic Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 ????Boston Scientific
        6.3.2 Tumor Ablation Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 ????Boston Scientific Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 ????Galil Medical
        6.4.2 Tumor Ablation Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 ????Galil Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 ????Neuwave Medical
        6.5.2 Tumor Ablation Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 ????Neuwave Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 ????Misonix
        6.6.2 Tumor Ablation Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 ????Misonix Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 ????Merit Medical
        6.7.2 Tumor Ablation Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 ????Merit Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 ????Sonacare Medical
        6.8.2 Tumor Ablation Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 ????Sonacare Medical Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 ????EDAP TMS
        6.9.2 Tumor Ablation Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 ????EDAP TMS Tumor Ablation Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Tumor Ablation Manufacturing Cost Analysis
    7.1 Tumor Ablation Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Tumor Ablation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Tumor Ablation Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Tumor Ablation Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Tumor Ablation Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Tumor Ablation Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Tumor Ablation Sales Volume Forecast by Type (2017-2022)
    11.3 United States Tumor Ablation Sales Volume Forecast by Application (2017-2022)
    11.4 United States Tumor Ablation Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer